[1]Henter JI,Soder O,Ost A,et al.Incidence and clinical features of familial hemophagocytic Lymphohistiocytosis in Sweden[J].Acta Paediatr Scand,1991,80(3):428-435.
[2]Henter JI,Arico M,Egeler M,et al.HLH-94:A treatment pro-
tocol for hemophagocytic lymphohistiocytosis[J].Med Pediatr Oncol,1997,28(2):342-347.
[3]Schneider EM,Lorenz I,Muller-Rosenberger M,et al.Hemop-
hagocytic lymphohistiocytosis (HLH)is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer cell induced apoptosis[J].Blood,2002,100(12):2891-2898.
[4]Bizario JC,Feldmann J, Castro FA, et al.Griscelli syndrome:Characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene[J].J Clin Immunol,2004,24(3):397-410.
[5]Emmenegger U, Schaer DJ, Larroche C,et al.Haemophagoc-
ytic syndromes in adults:current concepts and challenges ahead[J].Swiss Med Wkly,2005,135(3):299-314.
[6] Janka GE,Schenider EM.Modern management of children with haemophagocytic lymphohistiocytosis[J].Br J Haematol,2004,124(1):4-14.
[7]Henter JI,Tondini C,Pritchard J.Histiocytic syndromes[J].Crit Rev Oncol Hematol,2004,50(1):157-174.
[8]Henter JI,Horne AC,Arico M,et al.HLH-2004:diagnostic and therapeutic guidelines for hemophagotic lymphohistiocyt-
osis[J].Pediar Blood Cancer,2007,48(1):124-131.
[9]铃木信宽.血球贪食症侯群[J].临床血液,2007,48(10):159-168.
[10] Molleran Lee S,Villanueva J, Sumegi J, et al. Characteri-sation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with hae-mophagocytic lymphohistiocytosis[J].J Med Genet,2004,41(1):137-144.
[11]Zur Stadt U,Schmidt S,Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis(FHL)type-4 to chromosome 6q24 and identification of mutations in syntaxin 11[J].Hum Mol Genet,2005,14(4):827-834.
[12]Henter JI,Samuelsson-Horne AC,Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation[J].Blood,2002,100(11):2367-2373.
[13]Haddad E,Sulis ML,Jabado N,et al.Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis[J].Blood,1997,89(4):794-800.
[14]Imashuku S,Kuriyama K,Teramura T,et al.Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J].J Clin Oncol,2001,19(12):2665-2673.
[15] Horne AC,Janka G,Egeler RM,et al.Hematopoietic stem cell transplantation in hemophagocytic lym-phohistiocytosis[J].Br J Haematol,2005,129(4):622-630.
[16]Henter JI,Samuelsson-Home A,Arico M,et al.Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunoc-
hemotherapy and bone marrow transplantation[J].Blood,2002,100(7):2367-2373.
[17]Imashuku S,Kuriyama K,Teramura T,et al.Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J].J Clin Oncol,2001,19(12):2665-2673.
[18]Ouachee-Chardin M,Elie C,de Saint Basile G,et al.Hemato-
poietic stem cell transplantation in hemophagocytic lymphohistiocytosis:A single-center report of 48 patients[J].Pediatrics,2006,117:e743-e750.
[19]Cooper N,Rao K,Gilmour K,et al.Stem cell transplantation with reduced intensity conditioning for haemophagocytic lymphohistiocytosis[J].Blood,2007,107(3):1233-1236.
[20]Horne AC,Zheng C,Lorenz I,et al.Subtyping of natural kil-
ler cell cytotoxicity deficiencies in hemophagocytic lymphohistiocytosis provides therapeutic guidance[J].Br J Haematol,2005,129(4):658-666.